Pathstone Holdings’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $815K | Sell |
24,678
-5,441
| -18% | -$180K | ﹤0.01% | 1490 |
|
|
2025
Q1 | $1.21M | Buy |
30,119
+3,825
| +15% | +$153K | 0.01% | 1278 |
|
|
2024
Q4 | $1.24M | Sell |
26,294
-8,266
| -24% | -$389K | 0.01% | 1249 |
|
|
2024
Q3 | $1.82M | Buy |
34,560
+5,027
| +17% | +$265K | 0.01% | 1027 |
|
|
2024
Q2 | $1.6M | Buy |
29,533
+10,615
| +56% | +$575K | 0.01% | 1035 |
|
|
2024
Q1 | $1.33M | Buy |
18,918
+7,943
| +72% | +$557K | 0.01% | 1111 |
|
|
2023
Q4 | $916K | Buy |
+10,975
| New | +$916K | ﹤0.01% | 1126 |
|